These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 17542287)

  • 1. [NAFLD and metabolic syndrome a troublesome association].
    Reyes RB
    Rev Gastroenterol Mex; 2006; 71(4):510-1. PubMed ID: 17542287
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolic syndrome and NASH.
    Marchesini G; Marzocchi R
    Clin Liver Dis; 2007 Feb; 11(1):105-17, ix. PubMed ID: 17544974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonalcoholic fatty liver disease as a feature of the metabolic syndrome.
    Socha P; Wierzbicka A; Neuhoff-Murawska J; Włodarek D; Podleśny J; Socha J
    Rocz Panstw Zakl Hig; 2007; 58(1):129-37. PubMed ID: 17711101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic fatty liver disease: hepatic manifestation of obesity and the metabolic syndrome.
    Boppidi H; Daram SR
    Postgrad Med; 2008 Jul; 120(2):E01-7. PubMed ID: 18654060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonalcoholic fatty liver disease: a practical approach to evaluation and management.
    Rafiq N; Younossi ZM
    Clin Liver Dis; 2009 May; 13(2):249-66. PubMed ID: 19442917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatty liver: a novel component of the metabolic syndrome.
    Kotronen A; Yki-Järvinen H
    Arterioscler Thromb Vasc Biol; 2008 Jan; 28(1):27-38. PubMed ID: 17690317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of metabolic syndrome, nonalcoholic fatty liver disease and chronic hepatitis C.
    Rafiq N; Younossi ZM
    Expert Rev Gastroenterol Hepatol; 2008 Apr; 2(2):207-15. PubMed ID: 19072356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of non-alcoholic fatty liver disease on accelerated metabolic complications.
    Fan JG
    J Dig Dis; 2008 May; 9(2):63-7. PubMed ID: 18419637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonalcoholic fatty liver disease and metabolic syndrome: a concise review.
    Streba LA; Cârstea D; Mitruţ P; Vere CC; Dragomir N; Streba CT
    Rom J Morphol Embryol; 2008; 49(1):13-20. PubMed ID: 18273497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-alcoholic fatty liver disease: the mist gradually clears.
    de Alwis NM; Day CP
    J Hepatol; 2008; 48 Suppl 1():S104-12. PubMed ID: 18304679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonalcoholic fatty liver disease in India--is it different?
    Duseja A
    Trop Gastroenterol; 2006; 27(4):142-6. PubMed ID: 17542290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a lifestyle intervention in patients with abnormal liver enzymes and metabolic risk factors.
    St George A; Bauman A; Johnston A; Farrell G; Chey T; George J
    J Gastroenterol Hepatol; 2009 Mar; 24(3):399-407. PubMed ID: 19067776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nonalcoholic steatohepatitis].
    Poralla T
    Dtsch Med Wochenschr; 2005 Dec; 130 Suppl 5():S225-6. PubMed ID: 16435718
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolic syndrome, non-alcoholic fatty liver disease and hepatitis C virus: impact on disease progression and treatment response.
    Younossi ZM; McCullough AJ
    Liver Int; 2009 Mar; 29 Suppl 2():3-12. PubMed ID: 19187068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population.
    Dassanayake AS; Kasturiratne A; Rajindrajith S; Kalubowila U; Chakrawarthi S; De Silva AP; Makaya M; Mizoue T; Kato N; Wickremasinghe AR; de Silva HJ
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1284-8. PubMed ID: 19476560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is liver fat detrimental to vessels?: intersections in the pathogenesis of NAFLD and atherosclerosis.
    Loria P; Lonardo A; Targher G
    Clin Sci (Lond); 2008 Jul; 115(1):1-12. PubMed ID: 19016656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Metabolic syndrome and NAFLD/NASH].
    Tamura Y; Sato F; Kawamori R
    Nihon Rinsho; 2006 Dec; 64 Suppl 9():449-52. PubMed ID: 17458261
    [No Abstract]   [Full Text] [Related]  

  • 18. Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: an open question.
    Loria P; Lonardo A; Bellentani S; Day CP; Marchesini G; Carulli N
    Nutr Metab Cardiovasc Dis; 2007 Nov; 17(9):684-98. PubMed ID: 17560098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How should we manage patients with non-alcoholic fatty liver disease in 2007?
    Chan HL; de Silva HJ; Leung NW; Lim SG; Farrell GC;
    J Gastroenterol Hepatol; 2007 Jun; 22(6):801-8. PubMed ID: 17565632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic fatty liver.
    Nagi DK; Vani DH
    Diabet Med; 2005 Jan; 22 Suppl 1():14-8. PubMed ID: 15610151
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.